💰National Institute on Drug Abuse Grant Evaluation Meetings Notice
The Department of Health and Human Services announces closed meetings for the National Institute on Drug Abuse’s Special Emphasis Panel, focusing on the review of grant applications related to research mitigating the overdose crisis. Meetings will be held virtually to assess various proposal evaluations.
Learn More💰NIH Closed Meetings for Grant Application Review Notice
The National Institutes of Health issues a notice of closed meetings aimed at reviewing and evaluating grant applications related to significant health and scientific research. The meetings, occurring virtually, involve various specialized panels assessing proposals in areas such as hypertension and biochemistry, highlighting the importance of confidential information and potential funding for researchers and institutions.
Learn More💵NIH Notice
The Department of Health and Human Services announces closed meetings by the Center for Scientific Review to evaluate grant applications related to neuroscience and health interventions. The meetings are closed to the public to protect sensitive information, and they will be conducted virtually, providing crucial insights for stakeholders in health research funding.
Learn More💉Notice of Closed Meeting for HIV/AIDS Research Grant Review
The National Institute of Allergy and Infectious Diseases announces a closed meeting to evaluate grant applications related to HIV/AIDS research. The meeting aims to assess the proposals that may involve confidential trade secrets and personal information. Attendance is limited to invited participants, ensuring the integrity of sensitive discussions surrounding health innovations.
Learn More💰NIH Grant Review Meeting Notice
The National Institute of Diabetes and Digestive and Kidney Diseases has scheduled a closed meeting to discuss grant applications aimed at advancing research in diabetes, digestive diseases, and kidney health. The meeting is set for April 9, 2025, and will be conducted virtually, ensuring confidentiality concerning sensitive information shared during discussions.
Learn More🧬NIH Notice of Closed Meeting on Grant Proposals for Health Research
The Department of Health and Human Services announces a closed meeting of the National Institute of Allergy and Infectious Diseases to evaluate grant proposals related to neuroHIV research. The meeting emphasizes the confidentiality of discussed materials and includes details about the committee, its agenda, and contact information for inquiries.
Learn More💼Notice of NIH Meeting on TB Research Grant Applications
The Department of Health and Human Services announces a closed meeting by the National Institute of Allergy and Infectious Diseases to review grant applications related to tuberculosis research. The meeting is not open to the public and focuses on evaluating confidential information, including trade secrets and personal data associated with the applications.
Learn More🎗️National Cancer Institute Grant Evaluation Meeting Notice
The National Cancer Institute announces closed meetings to review grant applications for innovative technologies in cancer research. The meetings, scheduled for April 2025, aim to evaluate proposals that may involve confidential commercial and personal information. These discussions are part of regulatory compliance under the Federal Advisory Committee Act.
Learn More🏥NIEHS Notice
The Department of Health and Human Services announces a public meeting of the Board of Scientific Counselors from the National Institute of Environmental Health Sciences. The meeting will cover evaluations of grant applications and include various open sessions for public participation, providing stakeholders a chance to engage with NIH processes.
Learn More💰NIH Announces Meeting to Review Grant Applications for Health Research
The National Institutes of Health has announced a closed meeting of the National Institute of Allergy and Infectious Diseases Special Emphasis Panel to review and evaluate grant applications. This meeting, taking place from May 5-7, 2025, is crucial as it involves discussions that could impact confidential trade secrets and commercial properties.
Learn More